GlassScriptPhysician profile
Nena Korunda
NPI 1154372399
$1,380.28
in general payments reported to CMS, 2019-2025
19 companies · $582 in 2025
The $582 reported for 2025 was more than what 76% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $46.96 · 2020: $12.34 · 2021: $176 · 2022: $388 · 2023: $74.16 · 2024: $101 · 2025: $582.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $757.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $757.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $451.54 | 2022-2025 | Farapulse, General - Pain Management |
| Medtronic, INC. | $243.85 | 2022-2025 | Intellis Adaptivestim |
| Edwards Lifesciences Corporation | $200.18 | 2025 | |
| Axonics, INC. | $114.30 | 2021 | |
| Abbott Laboratories | $69.12 | 2021-2024 | Eterna, Proclaim |
| Novartis Pharmaceuticals Corporation | $41.00 | 2019-2021 | |
| Amgen INC. | $30.17 | 2022-2024 | Evenity, Prolia |
| Radius Health, INC. | $30.07 | 2021-2024 | Tymlos |
| Protega Pharmaceutials INC | $22.14 | 2023 | Roxybond |
| Cvrx, INC. | $21.30 | 2025 | Barostim Neo System |
| Horizon Therapeutics Plc | $20.99 | 2023 | Krystexxa |
| Therapeuticsmd, INC. | $19.46 | 2019 | |
| Phathom Pharmaceuticals, INC. | $18.92 | 2025 | Voquezna |
| Abbvie INC. | $18.61 | 2024 | |
| Amarin Pharma, INC. | $17.80 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $17.21 | 2024 | Wegovy |
| Idorsia Pharmaceuticals US INC | $15.54 | 2023 | Quviviq |
| Pfizer INC. | $14.19 | 2019 | |
| Painteq LLC | $13.89 | 2024 | Painteq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nena Korunda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.